Prime Medicine (PRME) Accumulated Depreciation & Amortization: 2021-2025
Historic Accumulated Depreciation & Amortization for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $1.9 million.
- Prime Medicine's Accumulated Depreciation & Amortization rose 20.73% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 26.58%. This contributed to the annual value of $6.1 million for FY2024, which is 31.70% up from last year.
- As of Q3 2025, Prime Medicine's Accumulated Depreciation & Amortization stood at $1.9 million, which was up 0.91% from $1.9 million recorded in Q2 2025.
- Prime Medicine's Accumulated Depreciation & Amortization's 5-year high stood at $1.9 million during Q3 2025, with a 5-year trough of $200,000 in Q3 2021.
- For the 3-year period, Prime Medicine's Accumulated Depreciation & Amortization averaged around $1.5 million, with its median value being $1.5 million (2024).
- Data for Prime Medicine's Accumulated Depreciation & Amortization shows a peak YoY spiked of 259.04% (in 2023) over the last 5 years.
- Prime Medicine's Accumulated Depreciation & Amortization (Quarterly) stood at $261,000 in 2021, then soared by 233.33% to $870,000 in 2022, then skyrocketed by 43.33% to $1.2 million in 2023, then spiked by 37.69% to $1.7 million in 2024, then grew by 20.73% to $1.9 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $1.9 million for Q3 2025, versus $1.9 million for Q2 2025 and $1.7 million for Q1 2025.